Editorial Notes1 March 1971Streptozotocin and Metastatic InsulinomaSTEPHEN K. CARTER, M.D., LAWRENCE BRODER, M.D., REDFORD B. WILLIAMS, M.D.STEPHEN K. CARTER, M.D.Search for more papers by this author, LAWRENCE BRODER, M.D.Search for more papers by this author, REDFORD B. WILLIAMS, M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-74-3-445 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptThe Chemotherapy Program of the National Cancer Institute has among its major goals the development of new antineoplastic drugs. Its research program requires that all new drugs be clinically tested against a panel of six signal tumor types: adenocarcinoma of the breast, adenocarcinoma of the colon, bronchogenic carcinoma, acute lymphatic leukemia, acute myelocytic leukemia, and non-Hodgkin's poorly differentiated lymphoma. One of the difficulties in the clinical evaluation is the testing of new drugs against the uncommon or rare tumor types, such as functioning islet cell tumors of the pancreas. The history and development of streptozotocin outlines one approach to this...References1. HERR R, JAHNKE H, and ARGOUDELIS A: Structure of streptozotocin. J Amer Chem Soc 89:4808-4809, 1967 CrossrefMedlineGoogle Scholar2. HEINEMANN B and HOWARD A: Effect of compounds with both antitumor and bacteriophage-inducing activities on E. coli nucleic acid synthesis. Antimicrob Agents Chemother 5:488-492, 1965 MedlineGoogle Scholar3. Cancer Chemotherapy National Service Center screening data Google Scholar4. : Toxicity Studies on Streptozotocin. Final report to Cancer Chemotherapy National Service Center, 1962 Google Scholar5. RAKIETEN N, RAKIETEN M, and NADKARNI M: Studies on the diabetogenic action of streptozotocin. Cancer Chemother Rep 29:91-98, 1963 Google Scholar6. NICHOLS J: Studies on an adrenal cortical inhibitor, in The Adrenal Cortex. New York, Harper & Row, Publishers, Inc., 1961, p. 83 Google Scholar7. HUTTER A and KAHOE D: Ortho para 'DDD therapy for adrenal cortical carcinoma. Amer J Med 41:572-580, 1966 CrossrefMedlineGoogle Scholar8. MURRAY-LYON I, EDDLESTON A, and WILLIAMS R: Treatment of multiple hormone-producing malignant islet cell tumor with streptozotocin. Lancet 2:895-898, 1968 CrossrefMedlineGoogle Scholar9. SADOFF L: Effects of streptozotocin in a patient with islet carcinoma. Diabetes 18:675-678, 1969 CrossrefMedlineGoogle Scholar10. TAYLOR S, SCHWARTZ T, and ZANNINI J: Streptozotocin therapy for metastatic insulinoma. Arch Intern Med (Chicago) 126:654-657, 1970 CrossrefMedlineGoogle Scholar11. LIAW K, WEI T, and Hsu S: Treatment of malignant insulinoma with streptozotocin. J Surg Soc (China) 3:62-69, 1970 Google Scholar12. SADOFF L: The nephrotoxicity of streptozotocin. Cancer Chemother Rep 54:457-459, 1970 MedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAuthors: STEPHEN K. CARTER, M.D.; LAWRENCE BRODER, M.D.; REDFORD B. WILLIAMS, M.D.Affiliations: Cancer Therapy Evaluation Branch National Cancer Institute Bethesda, Md. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byUrologic ComplicationsAntidiabetogenic Effects of Separate and Composite Extract of Seed of Jamun (Eugenia jambolana) and Root of Kadali (Musa paradisiaca) in Streptozotocin-induced Diabetic Male Albino Rat: A Comparative StudyCytotoxicity, calmodulin and DNA lesions in cells treated with streptozotocinForced diuresis to reduce nephrotoxicity of streptozotocin in the treatment of advanced metastatic insulinoma.Investigational Drug InformationSpontanhypoglykämienClassification of Chemotherapeutic Agents According to their Mechanisms of ActionEndocrine TumorsRecent Trends in Chemotherapy of Solid TumorsStreptozotocin therapy in 22 cancer patientsStreptozotocin treatment for malignant insulinomaThe Cytostatic Therapy of Hormone Secreting Tumours of the GI TractInsulin and ACTH production by a streptozotocin responsive islet cell carcinomaEffects of streptozotocin on an islet cell carcinoma with hypercalcemiaPancreatic Islet Cell Carcinoma II. Results of Therapy with Streptozotocin in 52 PatientsLAWRENCE E. BRODER, M.D., STEPHEN K. CARTERNew cancer chemotherapeutic agentsSome Antineoplastic AntibioticsLate Effects of Small-Cell Lung Cancer Treatment 1 March 1971Volume 74, Issue 3 Page: 445-446 Keywords Acute myeloid leukemia Adenocarcinoma Chemotherapy Colon Drug research and development Drugs Insulinoma Lymphoma Pancreas Precursor cells ePublished: 1 December 2008 Issue Published: 1 March 1971 PDF downloadLoading ...
No takes yet. Share an insight, caveat, or question.
Stephen K. Carter (1971) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: